Etop Ibcsg Partners Foundation

This study looks at whether adding a precise type of radiation (stereotactic radiosurgery) to standard drug treatments can better control brain tumors in people with melanoma or non-small cell lung cancer that has spread to the brain. About 180 participants with newly diagnosed, …

This study tests a drug called tarlatamab in 48 people with extensive-stage small cell lung cancer who have already tried one standard treatment. The drug is given through a vein and aims to control the cancer and help patients live longer. The main goal is to see how many patien…

This study tests whether the drug cemiplimab, given after surgery, can delay the return of non-small cell lung cancer in patients with stage II-IIIA. About 390 participants will either receive cemiplimab infusions or be observed without treatment. The goal is to see if the drug i…

This study tests whether adding the drug niraparib to standard maintenance therapy can help control extensive-stage small cell lung cancer in people whose tumors have a specific marker (SLFN11-positive). About 44 participants will take a daily niraparib pill along with an anti-PD…

This phase 3 trial tests whether giving the immunotherapy drug durvalumab after surgery and initial chemo-immunotherapy can delay or prevent lung cancer from returning in people with stage IIB-IIIB non-small cell lung cancer. About 290 participants will receive either durvalumab …